BEIJING SCIENCE SUN PHARMACEUTICAL CO., LTD.

Beijing Science Sun Pharmaceutical Co., Ltd.

300485

CNE100002110

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 03:30:00 07/06/2024 am IST			5-day change	1st Jan Change
6.53 ^CNY	+5.32%		-10.06%	-38.34%

23/05	Beijing Science Sun Pharmaceutical Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2023, Payable on 29 May 2024	CI
06/05	Beijing Science Sun Pharmaceutical Co., Ltd. Approves Cash Dividend for 2023	CI

Beijing Science Sun Pharmaceutical Co., Ltd.(XSEC:300485) dropped from S&P Global BMI Index

December 19, 2022 at 10:30 am IST

Latest news about Beijing Science Sun Pharmaceutical Co., Ltd.

Beijing Science Sun Pharmaceutical Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2023, Payable on 29 May 2024	23/05	CI
Beijing Science Sun Pharmaceutical Co., Ltd. Approves Cash Dividend for 2023	07/05	CI
Beijing Science Sun Pharmaceutical Co., Ltd. agreed to acquire 5.6664% stake in Suzhou Inhal Pharma Co., Ltd. from Ningbo Menovo Ruihe Equity Investment Partnership for CNY 10 million.	26/04	CI
Beijing Science Sun Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	25/04	CI
Beijing Science Sun Pharmaceutical Co., Ltd. Proposes Final Cash Dividend (Tax Included) for the Year 2023	10/04	CI
Beijing Science Sun Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	09/04	CI
Beijing Science Sun Pharmaceutical Co., Ltd. Announces Executive Changes	30/01	CI
Beijing Science Sun Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	26/23/26	CI
Beijing Science Sun Pharmaceutical Co., Ltd.(XSEC:300485) added to S&P Global BMI Index	18/23/18	CI
Beijing Science Sun Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	24/23/24	CI
Beijing Science Sun Pharmaceutical Co., Ltd. Announces 2022 Final Profit Distribution Plan to Be Implemented (A Shares), Payment Date of 23 May 2023	17/23/17	CI
Beijing Science Sun Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	25/23/25	CI
Beijing Science Sun Pharmaceutical Co., Ltd. Approves Final Dividend for 2022	22/23/22	CI
Beijing Science Sun Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for 2022	31/23/31	CI
Beijing Science Sun Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	13/23/13	CI
Lin Xuehua completed the acquisition of a 45% stake in Beijing Zhongrun Weiye Investment Co., Ltd. from Beijing Science Sun Pharmaceutical Co., Ltd. for CNY 6.6 million.	23/23/23	CI
Science Sun Pharma Passes Inspection of Premises	12/23/12	MT
Lin Xuehua intends to acquire 45% stake in Beijing Zhongrun Weiye Investment Co., Ltd. from Beijing Science Sun Pharmaceutical Co., Ltd. for CNY 6.65 million	07/23/07	CI
Beijing Science Sun Pharmaceutical Co., Ltd.(XSEC:300485) dropped from S&P Global BMI Index	19/22/19	CI
Beijing Science Sun Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	25/22/25	CI
Beijing Science Sun Pharmaceutical Co., Ltd.(XSEC:300485) added to S&P Global BMI Index	19/22/19	CI
Beijing Science Sun Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	25/22/25	CI
Beijing Science Sun Pharmaceutical Co., Ltd. Announces Cash Dividend for the Fiscal Year 2021, Payable on 31 May 2022	26/22/26	CI
Beijing Science Sun Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	28/22/28	CI
Beijing Science Sun Pharmaceutical Co., Ltd. Approves the Profit Distribution of Final Cash Dividend for the Year 2021	23/22/23	CI

Chart Beijing Science Sun Pharmaceutical Co., Ltd.

Duration

Period

Chart Beijing Science Sun Pharmaceutical Co., Ltd.

More charts

Beijing Science Sun Pharmaceutical Co., LTD. is a China-based company principally engaged in research, manufacture and sales of biological and biochemical pharmaceuticals. The Company' products can be divided into cardiovascular series, immune regulation series, nervous system series and other natural or biotech pharmaceuticals. Its products include small capacity injection and freeze-dried powder injection.

Sector

Pharmaceuticals

Calendar

23/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
BEIJING SCIENCE SUN PHARMACEUTICAL CO., LTD.	-38.34%	434M
ELI LILLY AND COMPANY	+45.82%	765B
NOVO NORDISK A/S	+40.95%	632B
JOHNSON & JOHNSON	-6.16%	354B
MERCK & CO., INC.	+19.86%	331B
ABBVIE INC.	+9.32%	299B
ASTRAZENECA PLC	+18.45%	248B
ROCHE HOLDING AG	-0.78%	219B
NOVARTIS AG	+11.88%	216B
AMGEN INC.	+5.90%	164B

Other Pharmaceuticals